Arnold C. Hanish, Director at Salarius Pharmaceuticals, Inc. (SLRX), sold 27 shares at $0.64 ($17) on 2025-12-30, disclosed to the SEC on 2026-01-02.
Open-market sale of $17 SLRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.64 | 12 | $8 | 44.4% |
| 2 | $0.64 | 15 | $10 | 55.6% |
| Total | $0.64 avg | 27 | $17 | 100% |
| Filing → |
| OMER | SELL | 2023-05-23 | $32K | — | Filing → |
| SLRX | BUY | 2022-06-06 | $5K | — | Filing → |
| SLRX | BUY | 2021-08-11 | $6K | — | Filing → |